_LIMITED.webp)
About Orphic Pharma (India) Limited
Data last updated:
Orphic Pharma (India) Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 May 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2003PLC042431. Its GSTIN is 24AAACO6767B1ZM (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹38.25 Lakh. It is led by directors including Patel Vinodkumar Babarbhai and Sunita Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 22 Sahjanand Kutir Munjamahuda Atladra, Vadodara, Gujarat, India – 390020.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.12 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹4.71 Lakh (net margin 1.5%) and EBITDA of ₹9.18 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 10% over five years.
The company is associated with 1 brand: Orphic Pharma. As per MCA filings, the company has open charges of ₹1.06 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orphicpharma.com.
Company details
Contact details
Orphic Pharma (India) Limited's registered office is in Vadodara, Gujarat. Its website is orphicpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 22 Sahjanand Kutir Munjamahuda Atladra, Vadodara, Gujarat, India – 390020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Orphic Pharma (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Orphic Pharma (India) operates one associated brand: Orphic Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting pharmaceutical medicines and drugs with a focus on quality and public health. | orphicpharma.com |
Business activity
The main business activity of Orphic Pharma (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Orphic Pharma (India) Limited, buy the company report.
Financials of Orphic Pharma (India) Limited
FY 2025 filings availableOrphic Pharma (India) Limited reported revenue of ₹3.12 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 33% growth in the latest year. EBITDA rose 264% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orphic Pharma (India) Limited, buy the company report.
Board of directors of Orphic Pharma (India) Limited
Orphic Pharma (India) has 8 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Patel Vinodkumar Babarbhai | Director | 27 May 2003 | 23 Years 5 Months | Current |
| Sunita Agrawal | Director | 27 May 2003 | 23 Years 5 Months | Current |
| Arpit Agrawal | Director | 21 Nov 2005 | 20 Years 11 Months | Current |
| Bharatbhai Mansukhbhai Kalavadiya | Director | 21 Jan 2016 | 10 Years 9 Months | Current |
| Mansukhlal Ranchhod Govani | Director | 27 May 2003 | 23 Years 5 Months | Current |
| Vinodbhai Ranchhodbhai Govani | Director | 30 Aug 2010 | 16 Years 1 Months | Current |
Peer comparison
Orphic Pharma (India) Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esteem Laboratories Private Limited | ₹3.14 Cr (FY 2021) | 178.0% | Hyderabad, Telangana, India | |||
| Prospero Pharmaceuticals Pvt Ltd | ₹3.13 Cr (FY 2025) | -11.0% | Kolkata, West Bengal, India | |||
| Orphic Pharma (India) Limitedthis company | ₹3.12 Cr (FY 2025) | ₹4.71 Lakh | 1.5% | 33.0% | Vadodara, Gujarat, India | |
| Crassula Pharmaceuticals Private Limited | ₹3.11 Cr (FY 2025) | 87.0% | Indore, Madhya Pradesh, India | |||
| Talin Remedies Private Limited | ₹3.11 Cr (FY 2025) | -9.0% | Amritsar, Punjab, India | |||
| Skylark Pharmaceuticals Private Limited | ₹3.11 Cr (FY 2024) | -40.0% | Ankleshwar, Gujarat, India | |||
| Amr Pharma India Private Limited | ₹3.11 Cr (FY 2019) | 158.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Orphic Pharma (India) Limited, buy the company report.
Auditor
Orphic Pharma (India) Limited is audited by PATHAK ANJARIA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PATHAK ANJARIA & CO | FY 2020 | 107782W |
Shareholding
The shareholding of Orphic Pharma (India) Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Orphic Pharma (India) Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2025 | 101136788 | Hdfc Bank Limited | ₹1.06 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Orphic Pharma (India) Limited has 4 court cases on record: 1 filed by Orphic Pharma (India), 3 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kollam, Kerala | Criminal case | Filed against the company by State of Kerala | Pending |
| District court, Kollam, Kerala | Criminal complaint | Filed against the company by State of Kerala | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, Kollam, Kerala | Criminal complaint | Filed against the company by State of Kerala Police | Disposed |
To see the full case history of Orphic Pharma (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orphic Pharma (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Orphic Pharma (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACO6767B1ZM | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Orphic Pharma (India) Limited, buy the company report.
Recent activity
Orphic Pharma (India) Limited has 12 board changes on record since 2003: 8 appointments and 4 cessations. The latest: Kamal Khairatilal Batra ceased to be Additional Director on 29 Sep 2023.
4 earlier events are in the company report.
Frequently asked questions
Orphic Pharma (India) is an active public limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 May 2003 (23+ years old) and is registered under CIN U24239GJ2003PLC042431.
Orphic Pharma (India) has 8 current directors:
- Patel Vinodkumar Babarbhai - Director
- Sunita Agrawal - Director
- Arpit Agrawal - Director
- Bharatbhai Mansukhbhai Kalavadiya - Director
- Mansukhlal Ranchhod Govani - Director
- Vinodbhai Ranchhodbhai Govani - Director
- Girish Chandra Agrawal - Director
- Kamal Khairatilal Batra - Director
The latest financial statements of Orphic Pharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Orphic Pharma (India) is 24AAACO6767B1ZM, registered in Gujarat.
The CIN (Corporate Identification Number) of Orphic Pharma (India) is U24239GJ2003PLC042431. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orphic Pharma (India) has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending.
Orphic Pharma (India) was incorporated on 27 May 2003, making it 23+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Orphic Pharma (India) by revenue are Esteem Laboratories Private Limited, Prospero Pharmaceuticals Pvt Ltd, Crassula Pharmaceuticals Private Limited, Talin Remedies Private Limited, Skylark Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kamal Khairatilal Batra ceased to be Additional Director on 29 Sep 2023. Kamal Khairatilal Batra was appointed as Director on 01 Oct 2022. Bharatbhai Mansukhbhai Kalavadiya ceased to be Additional Director on 29 Sep 2016. Orphic Pharma (India) has 12 board changes on record in total.
Orphic Pharma (India) can be reached through the website orphicpharma.com. Its registered office is in Vadodara, Gujarat, India.
The registered office of Orphic Pharma (India) is at Plot No. 22 Sahjanand Kutir Munjamahuda Atladra, Vadodara, Gujarat, India – 390020.